That is the GHK-Cu mechanism doing what it is designed to do, it accelerates the bodys own renewal process rather than introducing an external chemical change
2,3 GLP-1 Receptor Agonists: A Critical Look at the Evidence Two GLP-1 receptor agonists, semaglutide and liraglutide (Saxenda), are approved by the US Food and Drug Administration for treating obesity in adolescents 12 years and older with a BMI at the 95th percentile or higher
This is especially crucial for patients whose metabolic flexibility has been compromised, as it helps the body efficiently utilize stored fats for long-lasting energy, rather than relying solely on rapid, easily exhausted, and lactate-producing glucose stores
Accessed August 21, 2025.
Moonshot Cosmetics
How much does semaglutide 3mg cost